Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Connecticut's Blumenthal questions Smart Choices

This article was originally published in The Tan Sheet

Executive Summary

Connecticut Attorney General Richard Blumenthal follows other government officials in raising concern about the food industry's Smart Choices, a voluntary nutrition labeling program. Blumenthal wrote letters to food firms that participate in the program, such as Kellogg Co. and General Mills, expressing his concern and requesting information on the development of the program. Executives from the Smart Choices program say they will work with Blumenthal, according to media reports. Rep. Rosa DeLauro, D-Conn., wrote a letter to FDA in September, asking the agency to investigate whether Smart Choices allows firms to misrepresent unhealthy food as healthy (1"The Tan Sheet" Sept. 28, 2009). FDA and the Department of Agriculture are also inquiring about the program

You may also be interested in...



DeLauro Urges FDA To Probe Whether Smart Choices Really Are

Rep. Rosa DeLauro is pushing FDA to investigate whether the food industry's Smart Choices voluntary front-of-package nutrition labeling program allows companies to misrepresent unhealthy food choices as healthy

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.

Simplified Clinical Trial Transparency Rules To Go Live In The EU In June

A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103430

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel